TRDA: Entrada Therapeutics, Inc. Stock

by  •  • Comments Off on TRDA: Entrada Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 374.08
Enterprise Value ($M) 272.86
Book Value ($M) 428.68
Book Value / Share 12.03
Price / Book 0.87
NCAV ($M) 342.40
NCAV / Share 9.61
Price / NCAV 1.09

Profitability (mra)
Return on Invested Capital (ROIC) 0.13
Return on Assets (ROA) 0.14
Return on Equity (ROE) 0.27

Liquidity (mrq)
Quick Ratio 11.15
Current Ratio 11.15

Balance Sheet (mrq) ($M)
Current Assets 440.04
Assets 526.32
Liabilities 97.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 210.78
Operating Income 47.01
Net Income 65.63
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -41.56
Cash from Investing -27.80
Cash from Financing 102.96

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Janus Henderson Group Plc 5.60
02-14 13G/A Roche Finance Ltd 6.90 -6.38
02-04 13G BlackRock, Inc. 5.30
11-14 13G/A Price T Rowe Associates Inc /md/ 8.20 1.33
06-26 13D/A Baker Bros. Advisors Lp 13.20 3.43
2024-02-14 13G/A Redmile Group, LLC 3.80 -30.76

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 23,560 68,121 34.59
2025-03-10 27,851 89,430 31.14
2025-03-07 22,342 64,874 34.44
2025-03-06 19,585 68,802 28.47

(click for more detail)

Similar Companies
TKNO – Alpha Teknova, Inc. TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc. TRVI – Trevi Therapeutics, Inc.
TSBX – Turnstone Biologics Corp.


Financial data and stock pages provided by
Fintel.io